Drug profile · INN
alcohol
ALCOHOL 5% AND DEXTROSE 5%
alcohol (ALCOHOL 5% AND DEXTROSE 5%) is an FDA-listed pharmaceutical active ingredient. Route of administration: topical. Current US regulatory status: approved.
Drug details — alcohol
- US status
- approved
- Class
- —
- Route
- TOPICAL
- Patents
- 20
- Programs
- 121
- Data quality
- 0.84
Quick answer
alcohol (ALCOHOL 5% AND DEXTROSE 5%) is an FDA-listed pharmaceutical active ingredient. Route of administration: topical. Current US regulatory status: approved.
Key facts
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
Recent coverage
Pipeline programs
Related patents
-
US 20260125398
5,6-FUSED BICYCLIC ALCOHOL COMPOUNDS AS 15-PROSTAGLANDIN DEHYDROGENASE MODULATORS
granted -
US 12357590
Binge behavior regulators
granted -
US 12350242
Binge behavior regulators
granted -
US 12161621
Methods for fructokinase mediation of alcohol craving and alcohol induced liver disease
granted -
US 12064402
Binge behavior regulators
granted -
US 11951114
Use of thyroid beta-agonists
granted -
US 11896603
Oligosaccharide as therapeutic agent for alcohol associated liver disease
granted -
US 11622968
Heterocyclic modulators of lipid synthesis
granted -
US 11547736
Sauvignon blanc grape seed products for nonalcoholic fatty liver disease
granted -
US 11528924
Alcoholic beverage substitutes
granted -
US 11484523
Compositions for prevention and treatment of symptoms associated with alcohol consumption
granted -
US 11439635
B cell lymphoma 6 protein (BCL6) as a target for treating diabetes mellitus and non-alcoholic fatty liver disease
granted -
US 11400052
Alcohol-resistant drug formulations
granted -
US 11400072
Methods for the treatment of nonalcoholic fatty liver disease and/or lipodystrophy
granted -
US 11395848
Methods and compositions for treating diabetes
granted -
US 11357777
Use of sGC stimulators for the treatment of nonalcoholic steatohepatitis (NASH)
granted -
US 11351183
Use of thyroid beta-agonists
granted -
US 11298317
Alcoholic compositions having a lowered risk of acetaldehydemia
granted -
US 11291681
Method for treating fibrotic liver tissue using Cl-IB-MECA
granted -
US 11179384
Treatment of nonalcoholic fatty liver disease
granted
Frequently asked questions
What is alcohol?
alcohol (ALCOHOL 5% AND DEXTROSE 5%) is an FDA-listed pharmaceutical active ingredient. Route of administration: topical. Current US regulatory status: approved.
What is the brand name for alcohol?
ALCOHOL 5% AND DEXTROSE 5% is a marketed brand name for alcohol. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of alcohol?
alcohol has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.